Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-25

Clinical Trial Update: Tolerability of SLIT With LAIS® Mites Allergoid Tablets

View source ↗

Summary

This document provides an update on the tolerability of sublingual immunotherapy with LAIS Mites Allergoid Tablets for allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LAIS Mites Allergoid Tablets

Snippet

Sponsor: University Hospital of Cologne | Conditions: Allergic Rhinitis | Status: COMPLETED